Your browser doesn't support javascript.
loading
Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
Dang, Qun; Kasibhatla, Srinivas Rao; Reddy, K Raja; Jiang, Tao; Reddy, M Rami; Potter, Scott C; Fujitaki, James M; van Poelje, Paul D; Huang, Jingwei; Lipscomb, William N; Erion, Mark D.
Affiliation
  • Dang Q; Department of Medicinal Chemistry, Metabasis Therapeutics, Inc., La Jolla, California 92037, USA.
J Am Chem Soc ; 129(50): 15491-502, 2007 Dec 19.
Article in En | MEDLINE | ID: mdl-18041834
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Fructose-Bisphosphatase / Diabetes Mellitus, Type 2 / Enzyme Inhibitors / Hydrolases Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Journal: J Am Chem Soc Year: 2007 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Prodrugs / Fructose-Bisphosphatase / Diabetes Mellitus, Type 2 / Enzyme Inhibitors / Hydrolases Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals Language: En Journal: J Am Chem Soc Year: 2007 Document type: Article Affiliation country: United States Country of publication: United States